Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same

Details for Australian Patent Application No. 2009316874 (hide)

Owner AcelRx Pharmaceuticals, Inc.

Inventors Pushpala, Shamim; Hamel, Larry; Tzannis, Stelios; Cruz, Evangeline

Agent Pizzeys

Pub. Number AU-A-2009316874

PCT Pub. Number WO2010/059504

Priority 12/275,485 21.11.08 US

Filing date 12 November 2009

Wipo publication date 27 May 2010

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/4535 (2006.01)

Event Publications

7 July 2011 PCT application entered the National Phase

  PCT publication WO2010/059504 Priority application(s): WO2010/059504

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009316876-Directly compressible high functionality granular dibasic calcium phosphate based co-processed excipient

2009316867-Fixation plate for use in the Lapidus approach